Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (10): 36-43    DOI:
    
Expression of Herpes Simplex Virus Type 2 Latency-associated Transcript Open Reading Frames and Its Anti-apoptotic Effects
ZHONG Fei-fei1,2, YANG Hui-lan1, LÜ Fang-biao1,2, XUE Li-zhang1,2, BAI Li-li1,2, FAN Jian-yong1
1. Department of Dermatology, Guangzhou Liuhuaqiao Hospital, Guangzhou 510010, China;
2. School of Biological Science and Engineering, South China University of Technology, Guangzhou 510006, China
Download: HTML   PDF(1196KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Objective:To study the effects of herpes simplex virus type 2(HSV-2) latency-associated transcript(LAT) open reading frames(ORFs) on Vero cells which were induced apoptosis by agent. Methods:PCR amplified LAT ORF1, ORF2, ORF3 fragment,then construct recombinant plasmid pEGFP-ORF1,pEGFP-ORF2,pEGFP-ORF3,transfect them into Vero cells and identify its expression by RT-PCR.Using actinomycin D,5-FU and cisplatinere to induce Vero cells apoptosis,the changes of Vero cells morphology was observed by fluorescence microscopy.MTT assay was used to evaluate Vero cells viability and flow cytometry was used to calculate the cells apoptosis rate. Results:The pEGFP-ORF1,pEGFP-ORF2,pEGFP-ORF3 was constructed successfully which was confirmed by Double digestion and sequencing. Vero cells morphology were normal when transfected with pEGFP-ORFs and induced by apoptosis-inducing agent. MTT assay showed that the viabilities of Vero cells in recombinant plasmid group were no significant difference compared with the normal control group(P> 0.05), but remarkable higher than empty plasmid pEGFP-C2 group,the difference was significant(P<0.05).Flow cytometry assay showed that the cells apoptosis rate in pEGFP-ORFs group were no significant difference compared with the normal control group(P> 0.05),but was remarkable lower than the pEGFP-C2 group(P<0.05). Conclusion HSV-2 LAT ORFs gene can effectively expressed in Vero cells and can protect Vero cells from apoptosis.

Key wordsORFs      Herpes simplex virus      LAT      Apoptosis-inducing agent      Apoptosis      Vero cells     
Received: 19 July 2013      Published: 25 October 2013
ZTFLH:  Q819  
Cite this article:

ZHONG Fei-fei, YANG Hui-lan, LÜ Fang-biao, XUE Li-zhang, BAI Li-li, FAN Jian-yong. Expression of Herpes Simplex Virus Type 2 Latency-associated Transcript Open Reading Frames and Its Anti-apoptotic Effects. China Biotechnology, 2013, 33(10): 36-43.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2013/V33/I10/36

[1] Brinkman K K, Mishra P, Fraser N W. The half-life of the HSV-1 1.5-kb LAT intron is similar to the half-life of the 2.0-kb LAT intron. J Neurovirol, 2013, 19 (1): 102-108.
[2] Kent J R, Kang W, Miller C G, et al. Herpes simplex virus latency-associated transcript gene function. J Neurovirol, 2003, 9(3): 285-290.
[3] Kather A,Raftery M J,Devi-Rao G,et al.Herpes Simplex Virus Type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.J Virol, 2010, 84(2): 1034- 1046.
[4] Du T, Zhou G,Roizman B,et al.HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci U S A,2011, 108(26): 18820-18824.
[5] Sun L, Li Q. The miRNAs of herpes simplex virus (HSV). Virol Sin,2012,27(6)333-338.
[6] Johnston C,Saracino M,Kuntz S,et al.Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation:three randomised,open-label,cross-over trials. Lancet,2012,379(9816):641-647.
[7] Krause P R, Ostrove J M, Straus S E. The nucleotide sequence,5’ end,promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript. J Virol,1991, 65(10): 5619-5623.
[8] Li S,Carpenter D,Hsiang C,et al.Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (AKT) levels. J Gen Virol,2010,91(Pt 4):858-866.
[9] Jiang X Z,Chentoufi A A,Hsiang C H,et al.The Herpes Simplex Virus Type 1 latency-associated transcript can protect neuron-derived C1300 and neuro2A cells from granzyme B-induced apoptosis and CD8 T-Cell killing.J Virol,2011,85(5):2325-2332.
[10] Stefanidou M, Ramos I, Mas C V, et al.Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy.J Virol,2013,87(3):1443-1453.
[11] Ogawa Y, Kawamura T, Matsuzawa T, et al.Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.Cell Host Microbe,2013,13(1):77-86.
[12] Aziz A C,Xavier D,Pierre-Alain R,et al.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Curr Trends Immunol,2012,13:51-68.
[13] Carpenter D,Henderson G, Hsiang C,et al.Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity.Microb Pathog,2008,44(2):98-102.
[14] Thomas S K,Gough G,Latchman D S.A protein encoded by the herpes simplex virus(HSV) type 1 2-kilobase latency-associated transcript is phosphorylated,localized to the nucleus,and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.J Virol,2002, 76(8): 4056-406.
[15] Jin L, Perng G C, Mott K R, et al. A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse. J Virol,2005,79(19):12286-12295.
[16] Bertke A S, Apakupakul K, Ma A, et al. LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans. PLoS One,2012,7(12):e53281.
[1] LI Xiao-jin,LI Yan-meng,LI Zhen-kun,XU An-jian,YANG Xiao-xi,HUANG Jian. The Mechanism of Copper Accumulation Induced Autophagy in Hepatocytes of ATP7B-deficient Mice Based on RNA-sequencing[J]. China Biotechnology, 2021, 41(9): 10-19.
[2] WANG Xiao-jie,MENG Fan-qiang,ZHOU Li-bang,LV Feng-xia,BIE Xiao-mei,ZHAO Hai-zhen,LU Zhao-xin. Breeding of Brevibacillin Producing Strain by Genome Shuffling and Optimization of Culture Conditions[J]. China Biotechnology, 2021, 41(8): 42-51.
[3] FENG Zhao,LI Jiang-hao,WANG Jia-hua. Functional Analysis of RpRPL22, a Ribosomal Protein Homologous Gene, in the Symbiotic Nodulation Process of Robinia Pseudoacacia[J]. China Biotechnology, 2021, 41(7): 10-21.
[4] TAN Qing-li,LIN Dai-heng,LIU Jia-yuan,LIN Xing-chun. Study on the Benefits of Biomedical Industry in the Guangdong-Hong Kong-Macao Greater Bay Area Based on Grey Comprehensive Correlation Analysis[J]. China Biotechnology, 2021, 41(6): 89-97.
[5] TAO Shou-song,REN Guang-ming,YIN Rong-hua,YANG Xiao-ming,MA Wen-bing,GE Zhi-qiang. Knockdown of Deubiquitinase USP13 Inhibits the Proliferation of K562 Cells[J]. China Biotechnology, 2021, 41(5): 1-7.
[6] YAN Yu-jia,ZOU Ling. Research Progress on the Biogenesis and Function of piRNAs[J]. China Biotechnology, 2021, 41(5): 45-50.
[7] DUAN Yang-yang,ZHANG Feng-ting,CHENG Jiang,SHI Jin,YANG Juan,LI Hai-ning. The Effect of SIRT2 on Apoptosis and Mitochondrial Function in Parkinson’s Disease Model Cells Induced by MPP+[J]. China Biotechnology, 2021, 41(4): 1-8.
[8] LIN Yan-mei,LUO Xiang,LI Rui-jie,QIN Xiu-lin,FENG Jia-xun. Probing the Role of N-glycosylation on the Catalytic Domain in the Activity and Secretion of Fungal Cellobiohydrolase[J]. China Biotechnology, 2021, 41(4): 18-29.
[9] WANG Hui-lin,ZHOU Kai-qiang,ZHU Hong-yu,WANG Li-jing,YANG Zhong-fan,XU Ming-bo,CAO Rong-yue. Research Progress of Human Coagulation Factor VII and the Recombinant Expression Systems[J]. China Biotechnology, 2021, 41(2/3): 129-137.
[10] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[11] YANG Xi,LUAN Yu-shi. Preliminary Study of Sly-miR399 in Tomato Resistance to Late Blight[J]. China Biotechnology, 2021, 41(11): 23-31.
[12] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[13] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[14] DENG Rui,ZENG Jia-li,LU Xue-mei. Screening and Structure-activity Relationship Analysis of Anti-tumor Derived Peptides Based on Musca domestica cecropin[J]. China Biotechnology, 2021, 41(11): 14-22.
[15] ZHENG Yi,GUO Shi-ying,SUI Feng-xiang,YANG Qi-yu,WEI Ya-xuan,LI Xiao-yan. Applications of Quorum Sensing Systems in Synthetic Biology[J]. China Biotechnology, 2021, 41(11): 100-109.